Ross Sullivan, MD, FACMT
Dr. Sullivan completed his medical school education at SUNY Upstate Medical University in Syracuse, NY. After, he entered and finished a residency in Emergency Medicine at the same hospital. Dr. Sullivan then completed a medical toxicology fellowship at the SUNY Upstate Poison Control Center and SUNY Upstate Emergency Department. Dr. Sullivan is also board certified in Addiction Medicine. Dr. Sullivan is the Executive Medical Director of Helio Health (a community not-for-profit that offers substance use and psychiatric treatment), as well as the director of the medical toxicology fellowship and inpatient addiction medicine at SUNY Upstate Hospital. He also is the director of the Upstate Emergency Medicine Opioid Bridge Clinic; a program initiating buprenorphine in the ED with prompt referral to an ED based clinic .
Dr. Sullivan has co-authored several publications related to overdose and addiction, including “Cardiac conduction disturbance after loperamide abuse”, “Synthetic Cannabinoid Withdrawal”, “Baclofen overdose mimicking brain death”, “A randomized usability assessment of simulated naloxone administration by community members,” and recently “Bridge clinic buprenorphine program decreases emergency department visits”. Dr. Sullivan is currently a member of the Medical Advisory Panel to NY-OASAS (Office of Addiction Services and Support), the NY-DOH buprenorphine work group, as well as the Treasurer and Board Member of NYSAM (New York Society of Addiction Medicine)